Intec Pharma Ltd (NASDAQ:NTEC) shot up 10.4% on Monday . The stock traded as high as $5.82 and last traded at $5.65, with a volume of 86,693 shares. The stock had previously closed at $5.12.

Several research firms have weighed in on NTEC. Zacks Investment Research cut Intec Pharma from a “hold” rating to a “sell” rating in a research note on Tuesday, July 12th. Maxim Group restated a “buy” rating and set a $9.00 target price on shares of Intec Pharma in a research note on Tuesday, April 5th.

The company’s 50-day moving average price is $4.54 and its 200 day moving average price is $4.11. The stock’s market capitalization is $65.48 million.

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.